Galapagos NV ADR (GLPG)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
26.92 +0.05 (+0.19%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 26.92 unch (unch) 16:32 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | GLPG | ARWR | IDYA | ||
| Company | Galapagos NV ADR | Arrowhead Pharma | Ideaya Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.81 | 13.49 | 19.67 | ||
| High | 26.97 | 13.82 | 20.13 | ||
| Low | 26.58 | 13.29 | 19.35 | ||
| Last | 26.92 | 13.47 | 19.70 | ||
| Change | +0.05 | -0.05 | -0.05 | ||
| % Change | +0.19% | -0.37% | -0.25% | ||
| Volume | 283,300 | 1,112,800 | 1,174,300 | ||
| 20-Day Average Volume | 450,105 | 2,119,980 | 1,821,560 | ||
| Previous Close | 26.87 | 13.52 | 19.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.77 | 12.07 | 16.99 | ||
| 20-Day Raw Stochastic | 88.27% | 91.12% | 93.56% | ||
| 20-Day Relative Strength | 62.70% | 48.16% | 56.87% | ||
| Weighted Alpha | -4.20 | -55.47 | -52.97 | ||
| Today's Opinion | 8% Buy | 88% Sell | 56% Sell | ||
| Previous Opinion | 8% Sell | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.34% since 04/22/25 | +8.98% since 04/22/25 | +5.74% since 04/22/25 | ||
| Low | 25.32 on 04/23/25 | 12.76 on 04/23/25 | 18.56 on 04/25/25 | ||
| High | 27.50 on 04/28/25 | 13.85 on 04/28/25 | 20.13 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +5.73% since 03/28/25 | -2.53% since 03/28/25 | +15.54% since 03/28/25 | ||
| Low | 22.59 on 04/07/25 | 9.57 on 04/07/25 | 13.45 on 04/09/25 | ||
| High | 27.50 on 04/28/25 | 13.85 on 04/28/25 | 20.13 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +16.18% since 01/29/25 | -32.48% since 01/29/25 | -17.71% since 01/29/25 | ||
| Low | 22.36 on 02/10/25 | 9.57 on 04/07/25 | 13.45 on 04/09/25 | ||
| High | 27.50 on 04/28/25 | 21.84 on 02/07/25 | 25.59 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -5.68% since 10/29/24 | -32.58% since 10/29/24 | -34.03% since 10/29/24 | ||
| Low | 22.36 on 02/10/25 | 9.57 on 04/07/25 | 13.45 on 04/09/25 | ||
| High | 29.70 on 01/08/25 | 27.34 on 11/29/24 | 32.67 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,770,733 | 1,856,526 | 1,728,856 | ||
| Shares Outstanding, K | 65,900 | 137,317 | 87,537 | ||
| Annual Sales | 298,280,000 | 3,550,000 | 7,000,000 | ||
| Annual Net Income | 80,160,000 | -599,490,000 | -274,480,000 | ||
| Last Quarter Sales | 78,990,000 | 2,500,000 | 7,000,000 | ||
| Last Quarter Net Income | -161,610,000 | -173,090,000 | -130,310,000 | ||
| 60-Month Beta | 0.16 | 0.99 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.47 on 04/23/25 | -1.39 on 02/10/25 | -1.49 on 02/13/25 | ||
| Latest Earnings Date | 04/23/25 | 05/08/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||